Literature DB >> 1155429

Spherulin and coccidioidin: cross-reactions in dermal sensitivity to histoplasmin and paracoccidioidin.

H B Levine, A Restrepon, D R Eyck, D A Stevens.   

Abstract

Until recently coccidioidin has been the only antigenic preparation available for detecting delayed dermal sensitivity induced by an experience with Coccidioides immitis. It is prepared from autolysates of the mycelial phase (saprophytic) of the fungus. A more sensitive reagent, spherulin, was developed in 1969 from the spherule phase (parasitic) of the organism. Use of spherulin showed that coccidioidin failed to detect approximately 30% of individuals specifically sensitive to C. immitis. However the potential of spherulin to detect cross-sensitivity induced by Histoplasma capsulatum was unknown. This information was considered to be germane because of the capacity of coccidioidin to detect a histoplasmal experience. Accordingly, both reagents as well as paracoccidioidin were compared simultaneously in 365 Columbian soldiers from areas endemic for histoplasmosis but not for coccidioidomycosis. At standard strength both preparations detected nonspecific responses in 0.8% to 3% of the histoplasmin negative and positive subgroups, respectively. At 10-times standard strength both preparations cross-detected histoplasmin sensitivity comparably; 5.1% to 7.1% of histoplasmin-positive subjects reacted with the coccidioidal antigens. No pattern of cross-reactivity was observed between paracoccidioidin sensitivity and sensitivity to the coccidioidal antigens.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1155429     DOI: 10.1093/oxfordjournals.aje.a112122

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  10 in total

1.  A reformulated spherule-derived coccidioidin (Spherusol) to detect delayed-type hypersensitivity in coccidioidomycosis.

Authors:  Royce Johnson; Steven M Kernerman; Bradley G Sawtelle; Suresh C Rastogi; H Stewart Nielsen; Neil M Ampel
Journal:  Mycopathologia       Date:  2012-06-06       Impact factor: 2.574

Review 2.  Measurement of cellular immunity in human coccidioidomycosis.

Authors:  Neil M Ampel
Journal:  Mycopathologia       Date:  2003       Impact factor: 2.574

3.  In vitro lymphocyte responses of coccidioidin skin test-positive and -negative persons to coccidioidin, spherulin, and a coccidioides cell wall antigen.

Authors:  R A Cox; E Brummer; G Lecara
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

4.  Comparison of coccidioidin and spherulin in complement fixation tests for coccidioidomycosis.

Authors:  M Huppert; I Krasnow; K R Vukovich; S H Sun; E H Rice; L J Kutner
Journal:  J Clin Microbiol       Date:  1977-07       Impact factor: 5.948

5.  Delayed hypersensitivity responses of experimental animals to histoplasmin from the yeast and mycelial phases of Histoplasma capsulatum.

Authors:  G M Scalarone; H B Levine; S D Chaparas
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

6.  Antigenic analysis of coccidioidin and spherulin determined by two-dimensional immunoelectrophoresis.

Authors:  M Huppert; N S Spratt; K R Vukovich; S H Sun; E H Rice
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

7.  Disseminated coccidioidomycosis: a case report from the United kingdom.

Authors:  Wael I Al-Daraji; Riham M W Al-Mahmoud; Mahmud A Ali
Journal:  Int J Clin Exp Pathol       Date:  2008-06-04

8.  Reactivity to spherule-derived coccidioidin in the southeastern United States.

Authors:  W W Woodruff; C E Buckley; H A Gallis; J R Cohn; R W Wheat
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

9.  Comparisons of mycelia- and spherule-derived antigens in cellular immune assays of Coccidioides immitis-infected guinea pigs.

Authors:  R A Cox; C G Mead; E F Pavey
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

10.  Cost-effectiveness of a potential vaccine for Coccidioides immitis.

Authors:  A E Barnato; G D Sanders; D K Owens
Journal:  Emerg Infect Dis       Date:  2001 Sep-Oct       Impact factor: 6.883

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.